companies: 9,734     total market cap: C$151.329 T
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰$SGD🇸🇬
Acorda Therapeutics
ACOR
#9668
Rank
C$1.11 M
Marketcap
🇺🇸 USA
Country
$0.90
Share price
0.00%
Change (1 day)
-95.59%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -$13.44

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$13.26. In 2022 the company made an earnings per share (EPS) of -$119.63 an increase over its 2021 EPS that were of -$270.74.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.44-88.77%
2022-$119.63-55.81%
2021-$270.74-16.13%
2020-$322.82-65.51%
2019-$935.91-898.61%
2018$117.19-114.88%
2017-$787.79536.84%
2016-$123.70-392.31%
2015$42.32-39.53%
2014$69.994.88%
2013$66.73-89.54%
2012$638.04409.09%
2011$125.33-333.33%
2010-$53.71-85.14%
2009-$361.341.37%
2008-$356.4651.03%
2007-$236.01-68.27%
2006-$743.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Repligen
RGEN
$2.83-121.38%🇺🇸 USA
BioMarin Pharmaceutical
BMRN
$1.06-107.96%🇺🇸 USA
Affimed
AFMD
-$1.07-91.92%🇩🇪 Germany
Sarepta Therapeutics
SRPT
-$10.62-19.92%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
 CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com